Novel Therapeutics for Diabetic Micro- and Macrovascular Complications

E-ISSN： 1875-533x|13|15|1777-1788

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.13, Iss.15, 2006-06, pp. : 1777-1788

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Cardiovascular Risk Factors and Macrovascular and Microvascular Complications of Diabetes

Current Drug Targets, Vol. 4, Iss. 6, 2003-08 ,pp. : 477-486

Bentham Science Publishers

Access to resources Recommend Favorite

LOX-1, Oxidative Stress and Inflammation: A Novel Mechanism for Diabetic Cardiovascular Complications

By Yan Meiling

Cardiovascular Drugs and Therapy, Vol. 25, Iss. 5, 2011-10 ,pp. : 451-459

Springer Publishing Company

Access to resources Recommend Favorite

Micro- and Macrovascular Treatment Targets in Scleroderma Heart Disease

Current Pharmaceutical Design, Vol. 20, Iss. 4, 2014-02 ,pp. : 536-544

Bentham Science Publishers

Access to resources Recommend Favorite

Preventing macrovascular complications of diabetes: where do we stand with glycemic control?

By Athyros Vasilios G Tziomalos Konstantinos Karagiannis Asterios Mikhailidis Dimitri P

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 12, 2008-12 ,pp. : 1777-1779

Informa Healthcare

Access to resources Recommend Favorite

MicroRNAs in Cardiovascular Therapeutics

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 13, 2013-07 ,pp. : 1605-1618

Bentham Science Publishers

Access to resources Recommend Favorite